{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T12:16:20Z","timestamp":1777032980515,"version":"3.51.4"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Asociaci\u00f3n para la ayuda a la investigaci\u00f3n en Reumatolog\u00eda del Hospital Universitario de Canarias"},{"name":"Instituto de Salud Carlos III and European Union","award":["PI21\/00406"],"award-info":[{"award-number":["PI21\/00406"]}]},{"name":"Instituto de Salud Carlos III and European Union","award":["PI23\/00046"],"award-info":[{"award-number":["PI23\/00046"]}]},{"DOI":"10.13039\/501100013298","name":"Spanish Society of Rheumatology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013298","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The effects of systemic tumour necrosis factor (TNF) inhibition on glucose homeostasis are not fully understood. This study aims to evaluate the effects of TNF inhibitors (TNFis) on gastric inhibitory polypeptide (GIP), amylin and pancreatic polypeptide (PP), hormones involved in the fine-tuning of postprandial glucose homeostasis, in patients with RA, PsA and axial spondylarthritis (axSpA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Sixty-four non-diabetic patients (RA, n\u2009=\u200922; PsA, n\u2009=\u200913; axSpA, n\u2009=\u200929) undergoing TNFi therapy were prospectively evaluated at baseline and after 12, 24 and 52\u2009weeks. Assessments included measurements of disease activity, acute-phase reactants, fasting glucose, insulin and C-peptide levels, insulin resistance as assessed by the updated Homeostatic Model Assessment (HOMA)2 and lipid profile. Serum concentrations of amylin, GIP and PP were measured at each visit. Multivariable linear mixed-effects models were used to analyse temporal changes in clinical and biochemical variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Basal insulin resistance indices did not significantly change throughout the study in patients with RA, PsA or axSpA. However, serum basal levels of GIP, amylin and PP significantly increased in the univariable model, and the results remained consistent after adjusting for CRP, at 12, 24 and 52\u2009weeks of TNFi therapy. These effects were consistent and specific across different TNFi types and diagnoses, except for PP, which exhibited a significant interaction with the type of arthritis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients initiating TNFi therapy, serum levels of GIP, amylin and PP increase regardless of systemic inflammation. This effect on postprandial glucose-regulating hormones may help explain the cardiovascular benefits of TNFi in rheumatic inflammatory diseases, at least in part.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf601","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T13:10:19Z","timestamp":1763125819000},"source":"Crossref","is-referenced-by-count":1,"title":["Effects of systemic TNF inhibition on postprandial glucose-regulatory hormones in inflammatory arthritis"],"prefix":"10.1093","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0197-5267","authenticated-orcid":false,"given":"Iv\u00e1n","family":"Ferraz-Amaro","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Hospital Universitario de Canarias , Tenerife,","place":["Spain"]},{"name":"Department of Internal Medicine, Dermatology and Psychiatry, Universidad de La Laguna (ULL) , Tenerife,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0056-3132","authenticated-orcid":false,"given":"Marta","family":"Hern\u00e1ndez-D\u00edaz","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital Universitario de Canarias , Tenerife,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Carlos","family":"Garc\u00eda-Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital Universitario de Canarias , Tenerife,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Isabel Rodr\u00edguez","family":"Vargas","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital Universitario de Canarias , Tenerife,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8991-3241","authenticated-orcid":false,"given":"M\u00f3nica","family":"Renuncio-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Division of Immunology, Hospital de Le\u00f3n , Le\u00f3n,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2245-4639","authenticated-orcid":false,"given":"J Gonzalo","family":"Ocejo-Vinyals","sequence":"additional","affiliation":[{"name":"Division of Immunology, Hospital Universitario Marqu\u00e9s de Valdecilla, IDIVAL , Santander,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"L\u00f3pez-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Dermatology and Psychiatry, Universidad de La Laguna (ULL) , Tenerife,","place":["Spain"]},{"name":"Divisi\u00f3n of Endocrinology and Nutrition, Hospital Universitario de Canarias , Tenerife,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4139-9295","authenticated-orcid":false,"given":"Federico","family":"D\u00edaz-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital Universitario de Canarias , Tenerife,","place":["Spain"]},{"name":"Department of Internal Medicine, Dermatology and Psychiatry, Universidad de La Laguna (ULL) , Tenerife,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"2026022606020409000_keaf601-B1","doi-asserted-by":"crossref","first-page":"111785","DOI":"10.1016\/j.biopha.2021.111785","article-title":"Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19","volume":"140","author":"Patel","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"2026022606020409000_keaf601-B2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2217\/imt.15.4","article-title":"Investigating the potential side effects of anti-TNF therapy for rheumatoid arthritis: cause for concern?","volume":"7","author":"Atzeni","year":"2015","journal-title":"Immunotherapy"},{"key":"2026022606020409000_keaf601-B3","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.autrev.2010.07.011","article-title":"Biologics\u2014beyond the joints","volume":"9","author":"Szekanecz","year":"2010","journal-title":"Autoimmun Rev"},{"key":"2026022606020409000_keaf601-B4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijcard.2018.06.099","article-title":"Anti-TNF modulation reduces myocardial inflammation and improves cardiovascular function in systemic rheumatic diseases","volume":"270","author":"Ntusi","year":"2018","journal-title":"Int J Cardiol"},{"key":"2026022606020409000_keaf601-B5","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/jdv.19900","article-title":"Reducing cardiovascular risk in immune-mediated inflammatory diseases: tumour necrosis factor inhibitors compared to conventional therapies\u2014a systematic review and meta-analysis","volume":"38","author":"Galajda","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026022606020409000_keaf601-B6","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/ar4584","article-title":"The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study","volume":"16","author":"Ljung","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2026022606020409000_keaf601-B7","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3899\/jrheum.200265","article-title":"The risk of cardiovascular events associated with disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"48","author":"Ozen","year":"2021","journal-title":"J Rheumatol"},{"key":"2026022606020409000_keaf601-B8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13075-024-03352-3","article-title":"Impact of RA treatment strategies on lipids and vascular inflammation in rheumatoid arthritis: a secondary analysis of the TARGET randomized active comparator trial","volume":"26","author":"Liao","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"2026022606020409000_keaf601-B9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2174\/157339907782330012","article-title":"Insulin resistance and postprandial hyperglycemia the bad companions in natural history of diabetes: effects on health of vascular tree","volume":"3","author":"Di Filippo","year":"2007","journal-title":"Curr Diabetes Rev"},{"key":"2026022606020409000_keaf601-B10","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.dsx.2019.02.023","article-title":"Insulin resistance is a cardiovascular risk factor in humans","volume":"13","author":"Adeva-Andany","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"2026022606020409000_keaf601-B11","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1080\/07853890.2021.1902557","article-title":"One-hour post-load glucose improves the prediction of cardiovascular events in the OPERA study","volume":"53","author":"Saunajoki","year":"2021","journal-title":"Ann Med"},{"key":"2026022606020409000_keaf601-B12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4158\/EP.12.S1.47","article-title":"Postprandial hyperglycemia and cardiovascular disease","volume":"12 Suppl 1","author":"Gerich","year":"2006","journal-title":"Endocr Pract"},{"key":"2026022606020409000_keaf601-B13","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1038\/emm.2016.6","article-title":"Pancreatic regulation of glucose homeostasis","volume":"48","author":"Roder","year":"2016","journal-title":"Exp Mol Med"},{"key":"2026022606020409000_keaf601-B14","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"2026022606020409000_keaf601-B15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1210\/endrev\/bnaf006","article-title":"Glucose-dependent insulinotropic polypeptide in incretin physiology: role in health and disease","volume":"46","author":"Wolfe","year":"2025","journal-title":"Endocr Rev"},{"key":"2026022606020409000_keaf601-B16","first-page":"2822","article-title":"Deficiency of total and nonglycosylated amylin in plasma characterizes subjects with impaired glucose tolerance and type 2 diabetes","volume":"85","author":"Makimattila","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2026022606020409000_keaf601-B17","doi-asserted-by":"crossref","first-page":"102416","DOI":"10.1016\/j.npep.2024.102416","article-title":"Illuminating the neuropeptide Y(4) receptor and its ligand pancreatic polypeptide from a structural, functional, and therapeutic perspective","volume":"105","author":"Sch\u00fc\u00df","year":"2024","journal-title":"Neuropeptides"},{"key":"2026022606020409000_keaf601-B18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/joim.12743","article-title":"Defective glucose and lipid metabolism in rheumatoid arthritis is determined by chronic inflammation in metabolic tissues","volume":"284","author":"Arias de la Rosa","year":"2018","journal-title":"J Intern Med"},{"key":"2026022606020409000_keaf601-B19","doi-asserted-by":"crossref","first-page":"103001","DOI":"10.1016\/j.dsx.2024.103001","article-title":"The effects of anti-TNF-alpha biologics on insulin resistance and insulin sensitivity in patients with rheumatoid arthritis: an update systematic review and meta-analysis","volume":"18","author":"Lim","year":"2024","journal-title":"Diabetes Metab Syndr"},{"key":"2026022606020409000_keaf601-B20","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2026022606020409000_keaf601-B21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2026022606020409000_keaf601-B22","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2026022606020409000_keaf601-B23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/art.40726","article-title":"Special Article: 2018 American College of Rheumatology\/National Psoriasis Foundation Guideline for the treatment of psoriatic arthritis","volume":"71","author":"Singh","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2026022606020409000_keaf601-B24","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"key":"2026022606020409000_keaf601-B25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard-2022-223296","article-title":"ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update","volume":"82","author":"Ramiro","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2026022606020409000_keaf601-B26","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.2337\/dc25-SREV","article-title":"Summary of revisions: standards of care in diabetes\u20142025","volume":"48","author":"American Diabetes Association Professional Practice C","year":"2025","journal-title":"Diabetes Care"},{"key":"2026022606020409000_keaf601-B27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"2026022606020409000_keaf601-B28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/rheumatology\/keg072","article-title":"A simplified disease activity index for rheumatoid arthritis for use in clinical practice","volume":"42","author":"Smolen","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"2026022606020409000_keaf601-B29","first-page":"S100","article-title":"The simplified disease activity index (SDAI) and the clinical disease activity index (CDAI): a review of their usefulness and validity in rheumatoid arthritis","volume":"23","author":"Aletaha","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"2026022606020409000_keaf601-B30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2008.094870","article-title":"Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis","volume":"68","author":"Lukas","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2026022606020409000_keaf601-B31","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index","volume":"21","author":"Calin","year":"1994","journal-title":"J Rheumatol"},{"key":"2026022606020409000_keaf601-B32","first-page":"1694","article-title":"Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index","volume":"21","author":"Jenkinson","year":"1994","journal-title":"J Rheumatol"},{"key":"2026022606020409000_keaf601-B33","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/annrheumdis-2015-207507","article-title":"Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score","volume":"75","author":"Schoels","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2026022606020409000_keaf601-B34","doi-asserted-by":"crossref","first-page":"171186","DOI":"10.1016\/j.peptides.2024.171186","article-title":"Fasting and post prandial pancreatic and enteroendocrine hormone levels in obese and non-obese participants","volume":"176","author":"Bannon","year":"2024","journal-title":"Peptides"},{"key":"2026022606020409000_keaf601-B35","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/clinchem\/42.4.576","article-title":"Development of sensitive immunoassays to detect amylin and amylin-like peptides in unextracted plasma","volume":"42","author":"Percy","year":"1996","journal-title":"Clin Chem"},{"key":"2026022606020409000_keaf601-B36","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1210\/jcem-46-1-140","article-title":"Control of pancreatic polypeptide secretion by glucose in man","volume":"46","author":"Marco","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"key":"2026022606020409000_keaf601-B37","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/0026-0495(91)90065-5","article-title":"Understanding \"insulin resistance\": both glucose resistance and insulin resistance are required to model human diabetes","volume":"40","author":"Rudenski","year":"1991","journal-title":"Metabolism"},{"key":"2026022606020409000_keaf601-B38","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.clinbiochem.2014.02.007","article-title":"Age- and sex-specific reference values for fasting serum insulin levels and insulin resistance\/sensitivity indices in healthy Iranian adults: Tehran Lipid and Glucose Study","volume":"47","author":"Tohidi","year":"2014","journal-title":"Clin Biochem"},{"key":"2026022606020409000_keaf601-B39","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1055\/s-0031-1287783","article-title":"Systemic blockade of TNF-alpha does not improve insulin resistance in humans","volume":"43","author":"Ferraz-Amaro","year":"2011","journal-title":"Horm Metab Res"},{"key":"2026022606020409000_keaf601-B40","doi-asserted-by":"crossref","first-page":"R141","DOI":"10.1186\/ar3874","article-title":"Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance","volume":"14","author":"Stagakis","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"2026022606020409000_keaf601-B41","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"2026022606020409000_keaf601-B42","first-page":"850","article-title":"TNF-alpha antagonist therapy improves insulin sensitivity in non-diabetic ankylosing spondylitis patients","volume":"30","author":"Miranda-Filloy","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"2026022606020409000_keaf601-B43","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4239\/wjd.v12.i3.238","article-title":"Anti- and non-tumor necrosis factor-\u03b1-targeted therapies effects on insulin resistance in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis","volume":"12","author":"Wang","year":"2021","journal-title":"World J Diabetes"},{"key":"2026022606020409000_keaf601-B44","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.3390\/jcm11082207","article-title":"Mediators of amylin action in metabolic control","volume":"11","author":"Boyle","year":"2022","journal-title":"J Clin Med"},{"key":"2026022606020409000_keaf601-B45","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s13075-016-1148-1","article-title":"Effects of anti-TNF-\u03b1 treatment on lipid profile in rheumatic diseases: an analytical cohort study","volume":"18","author":"Hassan","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2026022606020409000_keaf601-B46","doi-asserted-by":"crossref","first-page":"14212","DOI":"10.1038\/s41598-017-14152-y","article-title":"Postprandial blood glucose outweighs fasting blood glucose and HbA1c in screening coronary heart disease","volume":"7","author":"Jiang","year":"2017","journal-title":"Sci Rep"},{"key":"2026022606020409000_keaf601-B47","doi-asserted-by":"crossref","first-page":"e0175982","DOI":"10.1371\/journal.pone.0175982","article-title":"Glycemic markers and relation with arterial stiffness in Caucasian subjects of the MARK study","volume":"12","author":"Gomez-Sanchez","year":"2017","journal-title":"PLoS One"},{"key":"2026022606020409000_keaf601-B48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0021-9150(99)00059-3","article-title":"Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals","volume":"144","author":"Hanefeld","year":"1999","journal-title":"Atherosclerosis"},{"key":"2026022606020409000_keaf601-B49","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s10067-023-06505-y","article-title":"Effect of TNF inhibitors on arterial stiffness and intima media thickness in rheumatoid arthritis: a systematic review and meta-analysis","volume":"42","author":"Abdulmajid","year":"2023","journal-title":"Clin Rheumatol"},{"key":"2026022606020409000_keaf601-B50","doi-asserted-by":"crossref","first-page":"102094","DOI":"10.1016\/j.molmet.2025.102094","article-title":"Chronic GIPR agonism results in pancreatic islet GIPR functional desensitisation","volume":"92","author":"Davies","year":"2025","journal-title":"Mol Metab"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf601\/65356042\/keaf601.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/2\/keaf601\/65356042\/keaf601.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/2\/keaf601\/65356042\/keaf601.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T11:02:14Z","timestamp":1772103734000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keaf601\/8325129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,4]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf601","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,11,17]]},"article-number":"keaf601"}}